ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

PBIRx, the Premier Pharmacy Benefit Consulting Firm, Celebrates 30 Years with Record Growth

PBIRx, Inc. is proud to mark its 30th anniversary as the premier pharmacy benefit auditing and consulting firm with a year of record-setting growth and a continued 99% client retention rate. Growth in 2023 extended to a significant investment in technology, the cornerstone of PBIRx’s data-driven solutions, outpacing the evolution of the ever-changing pharmacy benefit landscape. PBIRx also augmented its personnel with hiring growth in nearly all sectors.

“We are thrilled to celebrate this milestone,” said Patricia Sirowich, PBIRx Founder and President. “Our success is a testament to our team's dedication to providing our clients with personalized and innovative solutions. Pharmacy costs have grown to nearly 40% of healthcare dollars in 2023. We will continue to leverage our technology and expertise to help organizations navigate the complex pharmacy benefit environment, identify client-specific cost drivers, and achieve better outcomes for their members.”

PBIRx is not a PBM (pharmacy benefit manager). Since its founding as the first pharmacy benefit consulting and auditing firm in 1993, PBIRx has saved clients over $381 million, combating excessive profits of PBMs and pharmaceutical manufacturers. As a client advocate and educator, PBIRx’s primary goal is to manage pharmacy benefit costs for clients with a major sensitivity to their diverse cultures and needs.

“With over 30 years of experience, PBIRx epitomizes Pharmacy Benefit Intelligence,” said Sirowich. “Using precision negotiation and auditing techniques, we help our clients save on pharmacy benefit costs, allowing them to focus on what really matters: providing quality care to their members. This is one of many PBIRx differentiators. We are committed to serving our clients with the highest level of expertise and dedication, as we continue to revolutionize the pharmacy benefit industry with our intelligence-based solutions.”

PBIRx’s achievements:

  • First pharmacy benefit consultant
  • First to coin the term “pharmacy benefit consulting and auditing”
  • First to independently audit pharmacy benefits
  • AuditRx® – PBIRx’s propriety pharmacy benefit auditing platform
  • CTIRx® – PBIRx’s clinical technology intelligence & proprietary cost-saving algorithms
  • Independent, Certified Woman Owned Small Minority Business Enterprise
  • Inc. 5000 fastest growing company
  • SOC 2 Type 2 certified
  • Data encryption at rest – immediate inscription upon receipt
  • International prescription services
  • Specialty drug alternate funding solutions

About PBIRx

Our mission is to create optimal healthcare outcomes while minimizing overall healthcare costs. Established in 1993, PBIRx serves as a premier pharmacy benefit consulting firm providing intelligent management solutions. Our deep knowledge and advanced tools have helped us build lasting relationships and empower our clients to unravel the complexities of the ever-evolving pharmacy benefit industry. We are proud to be recognized as an Inc. 5000 fastest-growing company, a SOC 2 Type 2 certified company, and a certified Woman Owned Small Minority Business Enterprise.

To learn more, please visit PBIRx.com and follow @pbirx on X or PBIRx on LinkedIn.

"With over 30 years of experience, PBIRx epitomizes Pharmacy Benefit Intelligence,” said Sirowich. “Using precision negotiation and auditing techniques, we help our clients save on pharmacy benefit costs, allowing them to focus on what really matters."

Contacts

Media:

Angela Cross

PBIRx Marketing Communications Manager

across@pbirx.com

203-882-1188, ext. 220

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.